ストックスクリーナーアプリを入手
181.34
2.40%
-4.45
プレマーケット:
181.33
-0.010
-0.01%
Charles River Laboratories International Inc (CRL) 最新ニュース
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Can Charles River’s Portfolio Divestitures and “Pathway to Purpose” Strategy Reframe the CRL Investment Narrative? - simplywall.st
Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says - marketscreener.com
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Charles River (CRL) director awarded 422 restricted stock units as fees - Stock Titan
CRL: New strategy targets margin gains, tech integration, and growth, with DSA momentum building - TradingView
Charles River Laboratories International Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow (NYSE:CRL) 2026-06-03 - Seeking Alpha
Preclinical CRO Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research
Charles River Laboratories International Inc (CRL) Shares Fall 4 - GuruFocus
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
CRL (CRL) CFO Glenn Coleman receives 6,640-share equity grant at $180.71 - Stock Titan
CRL (NYSE: CRL) CIO receives stock grant; shares withheld for taxes - Stock Titan
Charles River (NYSE: CRL) EVP awarded 5,257 shares, 979 withheld - Stock Titan
CRL (NYSE: CRL) SVP Michael Knell awarded 1,837 shares, 200 used for tax withholding - Stock Titan
Charles River (NYSE: CRL) CEO awarded shares, withholds stock to pay tax - Stock Titan
James C. Foster (CRL) records tax-withholding share disposition and updates indirect holdings - Stock Titan
Charles River (NYSE: CRL) EVP gets 5,135-share award with tax withholding - Stock Titan
Charles River (NYSE: CRL) executive reports stock grant and tax withholding - Stock Titan
CRL: Operational efficiency, innovation, and portfolio focus drive growth and resilience - TradingView
CRL: Modernization, AI, and NAMs drive growth and margin expansion, with renewed DSA momentum - TradingView
Charles River Laboratories International Inc at William Blair Growth Stock Conference Transcript - GuruFocus
Charles River Shareholder Notice - TMX Newsfile
Charles River Laboratories to Present at William Blair and Jefferies Conferences 2026 - BioSpace
Charles River Laboratories (CRL) to Present at Key Investor Conf - GuruFocus
Charles River Laboratories to Present at William Blair and Jefferies Conferences - pharmiweb.com
CLSA upgrades Charles River Laboratories International (CRL) - MSN
Charles River Laboratories (CRL) Slides Slightly, Holds Near Key ResistanceMarket Cap Weight - thelegaladvocate.com
Charles River Laboratories Hits Day High with 10.24% Surge in Stock Price - Markets Mojo
CLSA upgrades Charles River Labs stock rating on regulatory outlook - Investing.com UK
CLSA upgrades Charles River Labs stock rating on regulatory outlook By Investing.com - Investing.com Nigeria
[Form 4] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading Activity - Stock Titan
Charles River (NYSE: CRL) executive logs tax-share withholding and trust gift - Stock Titan
Charles River Laboratories International Jumps 7.9% in Broad Rally - AlphaStreet
CRL (CRL) CEO Girshick delivers 618 shares for tax withholding, holds over 71K - Stock Titan
Charles River (NYSE: CRL) finance executive reports small tax-withholding share moves - Stock Titan
Charles River (CRL) EVP LaPlume reports 428-share tax-withholding disposals - Stock Titan
Charles River Laboratories International Inc (CRL) Shares Surge 5.0% -- What GF Score of 72 Tells Investors - GuruFocus
Wall Street Analysts Weigh in on Charles River Laboratories: Mixed Sentiment PersistsCash Flow Report - The Legal Advocate
Are Wall Street analysts bullish on Charles River Laboratories stock? - MSN
Are Wall Street Analysts Bullish on Charles River Laboratories Stock? - Yahoo Finance
CRL Q1 2026 Earnings: EPS Surpasses Estimates Amid Resilient OperationsEarnings Deceleration Risk - thelegaladvocate.com
Charles River Laboratories Inte (CRL) Stock Analysis: A 30% Upside Potential Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Cell Banking Outsourcing Market: 16%+ CAGR (2026-2031), Expanding with Rising Demand for Biologics and Regenerative Medicine Services, Says Mordor Intelligence - GlobeNewswire Inc.
Is Charles River (CRL) Quietly Recasting Its Moat Around AI Pathology And Cell Therapy Services? - Yahoo Finance
Should Higher Impairments and AI Investments Shape a New Capital Allocation Playbook for Charles River (CRL)? - simplywall.st
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
2.13%
2.22%
大文字化:
|
ボリューム (24 時間):